MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0140525

Медицинская библиотека · PloS one · 2015

Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis.

Schulze Kornelius, Weismüller Tobias J, Bubenheim Michael, Huebener Peter, Zenouzi Roman, Lenzen Henrike, Rupp Christian, Gotthardt Daniel, de Leuw Philipp, Teufel Andreas, Zimmer Vincent, Reiter Florian P, Rust Christian, Tharun Lars, Quaas Alexander, Weidemann Sören A, Lammert Frank, Sarrazin Christoph, Manns Michael P, Lohse Ansgar W, Schramm Christoph, German PSC Study Group

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND & AIMS: Current guidelines recommend immunosuppressive treatment (IT) in patients with primary sclerosing cholangitis (PSC) and elevated aminotransferase levels more than five times the upper limit of normal and elevated serum IgG-levels above twice the upper limit of normal. Since there is no evidence to support this recommendation, we aimed to assess the criteria that guided clinicians in clinical practice to initiate IT in patients with previously diagnosed PSC.

METHODS

This is a retrospective analysis of 196 PSC patients from seven German hepatology centers, of whom 36 patients had received IT solely for their liver disease during the course of PSC. Analyses were carried out using methods for competing risks.

RESULTS

A simplified autoimmune hepatitis (AIH) score >5 (HR of 36, p<0.0001) and a modified histological activity index (mHAI) greater than 3/18 points (HR 3.6, p = 0.0274) were associated with the initiation of IT during the course of PSC. Of note, PSC patients who subsequently received IT differed already at the time of PSC diagnosis from those patients, who did not receive IT during follow-up: they presented with increased levels of IgG (p = 0.004) and more frequently had clinical signs of cirrhosis (p = 0.0002).

CONCLUSIONS

This is the first study which investigates the parameters associated with IT in patients with PSC in clinical practice. A simplified AIH score >5 and a mHAI score >3, suggesting concomitant features of AIH, influenced the decision to introduce IT during the course of PSC. In German clinical practice, the cutoffs used to guide IT may be lower than recommended by current guidelines.

Для цитирования: Schulze Kornelius, Weismüller Tobias J, Bubenheim Michael, Huebener Peter, Zenouzi Roman, Lenzen Henrike, Rupp Christian, Gotthardt Daniel, de Leuw Philipp, Teufel Andreas, Zimmer Vincent, Reiter Florian P, Rust Christian, Tharun Lars, Quaas Alexander, Weidemann Sören A, Lammert Frank, Sarrazin Christoph, Manns Michael P, Lohse Ansgar W, Schramm Christoph, German PSC Study Group. Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis.. PloS one. 2015. DOI: 10.1371/journal.pone.0140525.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.